Main Content

Environmental, social and governance (ESG)

We believe in the life-changing potential of science for health care providers, their patients and communities. Our focus on improving patient health comes with a responsibility to have a positive impact on the world we share.

“At Boston Scientific, our environmental, social and governance (ESG) strategy is at the core of how we maximize value for our stakeholders. We carry out our strategy through ethical, sustainable and inclusive practices that enable business growth and achieve results.”

– Dan Brennan, Executive Vice President and Chief Financial Officer, Boston Scientific

2022 ESG Report

We are committed to understanding, managing and integrating ESG risks and opportunities into our business practices. Guided by these insights and our values, we are making measurable progress that advances science for life.

For more information on our progress, read our 2022 Performance Report.

View 2022 Performance Report View 2022 Disclosure Appendix

2022 Highlights

Environmental

We are committed to confronting climate change and challenging ourselves to meet ambitious environmental goals.

76%

renewable electricity, on track for our goal of 100% by 20241,2

40%

of energy from renewable sources, on track for our goal of 90% by 20272

SBTi approval

Net-zero and greenhouse gas emission reduction targets approved by the Science Based Targets initiative (SBTi)

1 Purchased electricity matched with electricity from renewable sources, inclusive of all manufacturing and key distribution sites only.
2 Inclusive of all manufacturing and key distribution sites only.

Social

We are dedicated to investing in our people so that together, we can impact global health disparities – breaking down barriers to improve patient lives.

42.6%

of supervisor and manager roles held by women globally

22.6%

by multicultural employees in the U.S., including Puerto Rico

99%

pay equity3

3 Figure from 2021 results. Analysis is completed every other year.

Governance

Ethics and integrity govern the work we do every day – we conduct business in a way that respects human life and enables us to make products that people trust.

~37 million

products delivered

97%

effectiveness in corrective and preventive action (CAPA) metrics and 99% on-time approvals

0 findings

resulting in action following more than 325 external audit days

All data as of December 31, 2022 unless otherwise specified.

View Full ESG Report Highlights


Invalid Listpath

Resources


Invalid Listpath

Connect with Boston Scientific Investor Relations

Investor relations contact

300 Boston Scientific Way
Mailstop M405
Marlborough, MA 01752
[email protected]